FindTrial
Sign In

New mechanism of IL-23/IL-23R--?dT—Th17/Treg axis in the occurrence and development of primary nephrotic sydnrome(PNS) in children

New mechanism of IL-23/IL-23R--?dT—Th17/Treg axis in the occurrence and development of primary nephrotic sydnrome(PNS) in children

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-CPC-17013714
Enrollment
Unknown
Registered
2017-12-05
Start date
2017-12-17
Completion date
Unknown
Last updated
2017-12-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Primary Nephrotic Syndrome

Interventions

primary nephrotic syndrome children versus health children:none

Sponsors

Children's Hospital of Chongqing Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 18 Years

Inclusion criteria

Inclusion criteria: 1. Children aged 0-18 years old and diagnosed with primary nephrotic syndrome without other infectious diseases.

Exclusion criteria

Exclusion criteria: And the child who used corticosteroid will be excluded.

Design outcomes

Primary

MeasureTime frame
quantity of ?dT cells;—

Countries

China

Contacts

Public ContactQiu Li

Chongqing Medical University

liqiu809@126.com+86 023-63603929

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026